london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Efficacy of micropulse 532 NM green laser in diabetic macular edema

Session Details

Session Title: Vascular Diseases and Diabetic Retinopathy II

Session Date/Time: Friday 12/09/2014 | 11:00-13:00

Paper Time: 11:00

Venue: Boulevard C

First Author: : K.Sousa PORTUGAL

Co Author(s): :    C. Ferreira   L. Mendonça   R. Gentil   R. Leite   F. Vaz   N. Gomes

Abstract Details

Purpose:

To evaluate our results using a 577 nm green micropulse laser for the treatment of diabetic macular edema.

Setting:

Ophthalmology department of Hospital de Braga, Portugal.

Methods:

This was a retrospective study of patients that were submitted to micropulse laser for the treatment of center-involving diabetic macular edema. We used a 577 nm green laser (Quantel SupraScan® 532nm) on areas of leakage as determined by fluorescein angiography. A subthreshold retinal photocoagulation was applied with a 10% duty-cycle of 200ms, 70% corresponding power of other retinal areas and a 50μm spot diameter. Best-corrected visual acuity (BVCA) was measured before and two-month after treatment. All the patients underwent SD-OCT, autofluorescence imaging (FAF) and fluorescein angiography (FA) before and after treatment. Retreatment criteria include aggravating edema, low visual acuity and target-lesion placed in no recommending conventional laser.

Results:

We analyzed 68 eyes of 50 patients that were treated with micropulse laser in our department. Forty-one of these were female. Mean age was 64.8 (45-84) years old. Central macular thickness variation after treatment ranged from -175μm to +138μm (mean variation: -17,96±47.1μm; p=0.002 vs. baseline; paired-sample-test). Mean BCVA improved 0.01 on decimal scale (p>0,05; paired-sample-test). FAF showed no changes after treatment but there was a decrease in the area of leakage on fluorescein angiography. There were no visible laser scars on any of the exams performed. Five patients had to repeat the treatment due to a lack of response. They all showed improvement after the second treatment.

Conclusions:

Micropulse 532 LASER alone was shown to reduce macular thickness and improve BCVA in diabetic patients with center-involving macular edema. One treatment is generally enough to cause an improvement in thickness or a decrease in leakage as seen on SD-OCT or fluorescein angiography. There were no visible scars on fundus exam, FAF and FA. Micropulse 532 LASER could be considered in in the treatment of center-involving diabetic macular edema, either alone or combined.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy